Looking for new fast-food items to try? Expand your horizon with these new breakfast, lunch, and dinner meals from McDonald's, Burger King, Subway, and more.

Novo Nordisk boasts 45 million customers using their drug Ozempic, which has caused a revolution in weight-loss treatment. Never before was there a drug that actually worked for weight loss.

For those who qualify, Ozempic offers benefits like improved blood sugar control Ozempic (semaglutide) is a prescription medication primarily used to manage type 2 diabetes. It belongs to a class ...

Some people who use semaglutide (Ozempic, others) have noted sagging skin in the buttocks, calling it “Ozempic butt.” While lifestyle modifications may help prevent this weight loss side ...

The list price for a one-month supply of Ozempic costs close to $1,000 without insurance or manufacturer coupons. According to CMS data, Medicare Part D spending on Ozempic was more than $4.6 ...

A new study reveals disappointing results on the potential of GLP-1 drugs like Ozempic to treat Parkinson's disease. Despite earlier hopes, a rigorous 96-week trial with 194 participants found no ...

Research shows that GLP-1 receptor agonists like Ozempic can help you drop weight, manage diabetes, and even potentially lower the risk of opioid overdoses. But now, a new study finds that taking ...

You may take Ozempic or another drug to control your diabetes or lose weight, but these so-called GLP-1s also have a host of other effects ‒ some good and some not so good. A new study ...

The US Food and Drug Administration (FDA) has approved Novo Nordisk's Ozempic to lower the risk of kidney failure and disease progression. According to a statement made by the Danish ...

Weight-loss drugs like Ozempic may decrease your risk of developing 42 health conditions, but increase your chance of experiencing 19 others, according to one of the most comprehensive studies-of ...

The move could mean savings for consumers. Weight loss drugs Ozempic and Wegovy have been added to the list of medications Medicare will be able to negotiate directly with drug manufacturers ...

Danish drugmaker Novo Nordisk, maker of the blockbuster diabetes and weight-loss treatments Ozempic and Wegovy, said on Wednesday its net profit jumped 21 per cent in 2024 to 100 billion Danish ...